NewEdge Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

NewEdge Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-407	Closed	-$6.83K	–	4291
2022 Q4	$6.83K	Sell	407 -11,485	-97%	-$454K	﹤0.01%	2484
2022 Q3	$561K	Buy	11,892 +911	+8%	+$58.8K	0.01%	911
2022 Q2	$787K	Buy	+10,981	New	+$803K	0.01%	789
2022 Q1	–	Sell	-8,683	Closed	-$892K	–	1713
2021 Q4	$892K	Buy	+8,683	New	+$834K	0.01%	792
2019 Q1	–	Sell	-5,226	Closed	-$206	–	718
2018 Q4	$206	Buy	+5,226	New	+$243K	0.01%	578

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

NewEdge Advisors's SYNH Position: Q1 2023 in Review

NewEdge Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 407 shares — an estimated $6.83K sold.

NewEdge Advisors first reported a position in SYNH in Q4 2018 and held it in 5 quarters. The position peaked at $892K in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

NewEdge Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 407 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $6.83K.
NewEdge Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 5 quarters.
NewEdge Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $892K in Q4 2021.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.